Table 1. Comparison of Demographic Characteristics, Cardioprotective Quality of Care Factors, and Medications Stratified by Smoking Status Among Those With Type 2 Diabetes With and Without Schizophrenia.
| Schizophrenia Non-Smokers (N=39) | Schizophrenia Smokers (N=61) | Non-SMI Non-Smoker (N=65) | Non-SMI Smokers (N=34) | Comparison between Schizophrenia Smokers and Schizophrenia Non- Smokers P-Value | Comparison between Schizophrenia Smokers and Non-SMI Smokers P-Value | |
|---|---|---|---|---|---|---|
| Demographic and Diabetes Related Factors | ||||||
| Age (Years±SD) | 48.1 (9.4) | 48.6 (8.7) | 54.8 (8.67) | 49.9 (8.4) | 0.76 | 0.49 |
| Male | 61.5% | 54.1% | 52.3% | 52.9% | 0.46 | 0.91 |
| White | 48.7% | 24.6% | 35.4% | 23.5% | 0.01 | 0.90 |
| HS Education | 74.4% | 62.3% | 63.1% | 73.5% | 0.21 | 0.27 |
| Duration of Illness | 6.7 (6.4) | 9.8 (8.5) | 7.4 (7.62) | 7.3 (6.8) | 0.05 | 0.14 |
| Hemoglobin A1C | 7.7 (2.1) | 7.9 (2.4) | 8.53 (2.33) | 8.9 (2.6) | 0.67 | 0.09 |
| BMI (kg/m2±SD) | 33.9 (6.4) | 32.0 (7.0) | 36.0 (6.86) | 32.8 (5.8) | 0.16 | 0.60 |
| History of Heart Problems | 23.1% | 22.9% | 28.8% | 18.2% | 0.99 | 0.56 |
| Use of Any Antipsychotic Medication | 98.4% | 97.4% | --N/A-- | --N/A-- | 0.75 | --N/A-- |
| Quality of care | ||||||
| Smoking Cessation Counseling | --N/A-- | 62.1% | --N/A-- | 79.4% | --N/A-- | 0.08 |
| Blood Pressure Exam | 100% | 86% | 96.7% | 100% | 0.03 | 0.03 |
| Lipid Profile | 89.7% | 67.4% | 91.5% | 96.7% | 0.03 | 0.002 |
| Medication | ||||||
| Statins | 25.6% | 9.8% | 43.1% | 32.4% | 0.03 | 0.01 |
| ACE Inhibitors | 25.6% | 14.8% | 58.5% | 50% | 0.18 | <0.01 |